Q2 2024 · 13F-HR
Rhenman & Partners Asset Management ABholdings as filed
Filed 2024-08-13 · accession 0001213900-24-067896
$1.04B
Reported value
93
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91324P102 | UNH | UNITED HEALTH GROUP INC | $53.6M | 5.15% | 105,300 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $46.5M | 4.46% | 85,800 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $45.8M | 4.40% | 595,000 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $42.6M | 4.09% | 47,000 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $33.6M | 3.23% | 32,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $32.4M | 3.11% | 189,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $30.5M | 2.92% | 229,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $30.2M | 2.90% | 1,906,611 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $27.1M | 2.60% | 310,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $26.9M | 2.58% | 60,500 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $26.9M | 2.58% | 440,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $26.4M | 2.54% | 113,000 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $26.3M | 2.53% | 82,000 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $25.3M | 2.43% | 54,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $24.5M | 2.35% | 74,171 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO. INC | $21.7M | 2.08% | 175,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $20.8M | 1.99% | 85,500 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $20.7M | 1.99% | 251,500 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $19.7M | 1.89% | 84,800 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $17.5M | 1.68% | 30,000 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $17.0M | 1.63% | 157,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $16.4M | 1.57% | 208,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $16.4M | 1.57% | 238,500 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $15.1M | 1.45% | 145,000 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $14.4M | 1.38% | 544,697 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $13.8M | 1.33% | 1,232,361 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $13.6M | 1.31% | 56,500 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $13.3M | 1.27% | 24,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $13.3M | 1.27% | 117,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $13.2M | 1.26% | 198,482 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $12.8M | 1.23% | 1,641,448 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $12.2M | 1.17% | 114,000 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $12.1M | 1.16% | 48,500 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $11.6M | 1.11% | 51,500 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $10.7M | 1.03% | 197,515 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $10.4M | 1.00% | 75,555 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $10.3M | 0.99% | 127,600 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $9.7M | 0.93% | 142,000 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $9.4M | 0.90% | 46,500 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $9.0M | 0.86% | 97,500 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $7.4M | 0.71% | 26,500 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $7.4M | 0.71% | 920,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $7.0M | 0.67% | 34,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.7M | 0.64% | 99,513 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $6.6M | 0.63% | 31,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $6.3M | 0.60% | 82,750 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $6.2M | 0.59% | 130,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $6.1M | 0.59% | 145,000 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $6.1M | 0.59% | 18,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $6.1M | 0.59% | 230,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $6.1M | 0.59% | 115,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $5.9M | 0.57% | 50,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $5.4M | 0.51% | 90,500 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $5.1M | 0.49% | 60,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $4.7M | 0.45% | 228,500 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $4.7M | 0.45% | 184,500 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $4.6M | 0.44% | 134,250 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.5M | 0.43% | 106,847 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $4.4M | 0.42% | 900,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $4.4M | 0.42% | 1,975,000 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $4.2M | 0.41% | 806,054 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $4.1M | 0.40% | 218,750 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $4.1M | 0.40% | 23,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.8M | 0.36% | 213,500 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $3.6M | 0.35% | 174,393 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.6M | 0.35% | 150,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $3.5M | 0.33% | 19,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.4M | 0.33% | 130,500 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY IN | $3.4M | 0.33% | 166,526 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO CALL | $3.1M | 0.30% | 65,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY INC | $2.7M | 0.26% | 39,824 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $2.3M | 0.22% | 17,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $2.1M | 0.20% | 55,395 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $2.1M | 0.20% | 7,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $2.0M | 0.20% | 13,500 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $2.0M | 0.19% | 114,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $2.0M | 0.19% | 58,278 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $1.9M | 0.18% | 53,500 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $1.8M | 0.17% | 701,707 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $1.6M | 0.15% | 178,284 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.5M | 0.14% | 230,000 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $1.4M | 0.14% | 20,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.4M | 0.13% | 35,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $1.3M | 0.13% | 195,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $1.3M | 0.13% | 4,250 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.3M | 0.12% | 120,250 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $1.3M | 0.12% | 60,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $1.3M | 0.12% | 10,000 | Common | SOLE |
| 58506Q109 | MEDP | MEDPACE HLDGS INC | $1.0M | 0.10% | 2,500 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $963,000 | 0.09% | 20,000 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $956,000 | 0.09% | 50,000 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $880,000 | 0.08% | 1,000,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $382,860 | 0.04% | 6,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.